LMNB1 and hepatocellular carcinoma: Earlier studies have been found that LMNB1 is a detectable protein present in the plasma of HCC patients and is upregulated in HCC cells; thus, it could be measured as a potential diagnostic biomarker to identify patients who are in the initial stage of HCC [85].